Report Warns Of Revenue Challenges In Biopharma

Jan. 13, 2005
Flat output from R&D labs, despite increased spending, will put pressure on revenue growth in the biopharma sector, according to a report from The Boston Consulting Group, "Rising to the Productivity Challenge: A Strategic Framework for Biopharma." The ...

Flat output from R&D labs, despite increased spending, will put pressure on revenue growth in the biopharma sector, according to a report from The Boston Consulting Group, "Rising to the Productivity Challenge: A Strategic Framework for Biopharma." The consulting firm's report says a gap in new blockbuster drug rollouts is partially to blame. Revenue growth in the 1990s came primarily from an increase in the number of blockbuster drugs produced: These drugs had a 105% growth rate from 1989 to 2004, while non-blockbuster growth declined 5%. Now that patent expirations are increasing, the stock of blockbuster drugs is approaching equilibrium, and the industry is threatened with the loss its main engine of growth. Meanwhile, promising drugs based on genomics are being developed but won't hit the market in time to offset the blockbuster expirations, the authors state. The report recommends reducing costs, enhancing the value of existing drugs and accepting product failures sooner to combat the expected dry spell. Another key finding is that while small biopharma companies account for less than 10% of market capitalization and R&D spending in relation to their larger brethren, small biopharma accounts for two-thirds of the industry's clinical pipeline. This sets the stage for even more intensive business relationships as larger companies seek to tap into this source of innovation.

Popular Sponsored Recommendations

Empowering the Modern Workforce: The Power of Connected Worker Technologies

March 1, 2024
Explore real-world strategies to boost worker safety, collaboration, training, and productivity in manufacturing. Emphasizing Industry 4.0, we'll discuss digitalization and automation...

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

Transformative Capabilities for XaaS Models in Manufacturing

Feb. 14, 2024
The manufacturing sector is undergoing a pivotal shift toward "servitization," or enhancing product offerings with services and embracing a subscription model. This transition...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!